Publications

5891 Results

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small cell lung cancer: Results of phase II Southwest Oncology Group study.

Authors
MB Hazuka;JJ Crowley;PA Bunn Jr;M O'Rourke;TJ Braun;RB Livingston
Journal / Conference
Journal of Clinical Oncology 12(9):1814-1820
Year
1994
Research Committee(s)
Lung
Study Number(s)
SWOG-8836

GM-CSF, carboplatin, doxorubicin: a phase I study

Authors
EA Poplin;DS Alberts;JJ Rinehart;HO Smith;JA Neidhart;EM Hersh
Journal / Conference
Cancer Chemotherapy and Pharmacology 33:340-346
Year
1994
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-8902

Phase II study of carboplatin (CBDCA) in refractory multiple myeloma: A Southwest Oncology Group study.

Authors
B Barlogie;J Crowley;SE Salmon;J Bonnet;JK Weick;K Hayden
Journal / Conference
Investigational New Drugs 12:53-55
Year
1994
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8944

Current trials and future directions of the Southwest Oncology Group (SWOG) Breast Cancer Committee.

Authors
CK Osborne
Journal / Conference
Cancer 74(3):1135-1138
Year
1994

Breast cancer outcome and predictors of outcome: Are there age differentials?

Authors
KS Albain;DC Allred;G Clark
Journal / Conference
Journal of the National Cancer Institute Monographs 16:35-42
Year
1994

SWOG 8609 - a phase II trial of teniposide (VM-26) as therapy for extensive small cell lung cancer (SCLC)

Authors
V Canfield;P Grozea;J Crowley;R Livingston
Journal / Conference
Lung Cancer 11(Suppl.1):102(#389)
Year
1994
Research Committee(s)
Lung
Study Number(s)
SWOG-8609

Phase II trial of dimethyl triazeno imidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.

Authors
RM Bukowski;CM Tangen;RF Peterson;SA Taylor;JJ Rinehart;HJ Eyre;SE Rivkin;T Fleming;JS Macdonald
Journal / Conference
Cancer 73(5):1505-1508
Year
1994
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8411

A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study

Authors
GB Selby;C Upchurch;J Townsend;HJ Eyre
Journal / Conference
Cancer Chemotherapy and Pharmacology 34(2):179-180
Year
1994
Research Committee(s)
Brain
Study Number(s)
SWOG-8834

Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma: A Southwest Oncology Group study.

Authors
JA Kish;M Wolf;ED Crawford;JT Leimert;A Bueschen;JR Neefe;RC Flanigan
Journal / Conference
Cancer 74(3):916-919
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8926

Prognostic significance of the Ki-67 associated proliferative antigen in aggressive non-Hodgkin's lymphoma: A prospective Southwest Oncology Group (SWOG) trial.

Authors
TP Miller;TM Grogan;S Dahlberg;CM Spier;RM Braziel;PM Banks;K Foucar;CR Kjeldsberg;N Levy;BN Nathwani;B Schnitzer;RR Tubbs;ER Gaynor;RI Fisher
Journal / Conference
Blood 83(6):1460-1466
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067), SWOG-8819